How Microdosing Can Backfire
Fat Science29 Syys 2025

How Microdosing Can Backfire

This week on Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright take a hard look at the buzz around microdosing metabolic medications—from what “microdosing” actually means to the risks of following trends without clinical supervision. The team unpacks widespread misunderstandings about dosing for drugs like Ozempic, Zepbound, and low-dose naltrexone (LDN), explains why social media advice can be dangerous, and highlights just how unique every person’s metabolic needs are.


Dr. Cooper shares patient examples and lays out the science behind hormone regulation, medication resistance, and why skipping a full evaluation could backfire. We cover why glandular extracts and testosterone supplements can disrupt your body’s natural balance and why trying to “trick” your metabolism with tiny doses can sometimes do more harm than good.


Key Takeaways:

  • Microdosing means doses far below anything supplied by drug companies—it’s not the same as prescribing a lower dose within the normal range.
  • Popular trends in LA and beyond push people toward self-experimentation, often with compounded drugs or unsupervised regimens.
  • Taking metabolic drugs without a clinical need can weaken natural hormone production and create dependency—even with “natural” supplements.
  • GLP-1s, GIPs, naltrexone, and testosterone all show very different outcomes depending on your genetics, history of dieting, childhood athletics, or use of other medications.
  • More is not always better. Too high a dose can create medication resistance, while too low might “numb out” your hormone response.
  • Professional evaluation, sleep, nutrition, and self-kindness remain the first line of defense for metabolic health, rather than skipping over those and heading straight to medication.

Resources from the episode: Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.

Check out our new website where you can ask a mailbag question. If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at questions@fatsciencepodcast.com or dr.c@fatsciencepodcast.com.

If you are a healthcare professional interested in Dr. Cooper's training course, go to FatSciencePodcast.com and click on the top right button for Provider Course.Connect with Dr. Emily Cooper on LinkedInConnect with Mark Wright on LinkedInConnect with Andrea Taylor on Instagram

Jaksot(129)

Mailbag: Food Tracking, Mechanical Eating Troubleshooting, COVID & Metabolism, and Metformin + GLP-1 Synergy

Mailbag: Food Tracking, Mechanical Eating Troubleshooting, COVID & Metabolism, and Metformin + GLP-1 Synergy

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor answer listener mailbag questions from California, the UK, France, Washington, Wyoming, and beyond. The team breaks down why ...

26 Tammi 41min

Mailbag: GLP-1 Weight Regain, Meals vs Snacks, and Why Some People Don’t Respond

Mailbag: GLP-1 Weight Regain, Meals vs Snacks, and Why Some People Don’t Respond

his week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor answer listener mailbag questions that get to the heart of metabolic health. The team explains the real difference between mea...

19 Tammi 41min

What the Headlines Get Wrong About GLP-1 Drugs and Metabolism

What the Headlines Get Wrong About GLP-1 Drugs and Metabolism

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor break down two GLP-1 studies that challenge a major media myth: GLP-1 medications don’t drive weight loss just because people...

12 Tammi 45min

GLP-1 Mailbag: Weight Regain, Leptin Resistance, Hypoglycemia & Why Calories Aren’t the Problem

GLP-1 Mailbag: Weight Regain, Leptin Resistance, Hypoglycemia & Why Calories Aren’t the Problem

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor tackle a wide-ranging mailbag episode with listener questions from the U.S., UK, and Europe. Topics include unexpected weight...

5 Tammi 39min

Childhood Obesity, Eating Disorders & GLP-1s: Why It’s Not Your Fault

Childhood Obesity, Eating Disorders & GLP-1s: Why It’s Not Your Fault

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor talk with pediatric eating disorder specialist Dr. Julie O’Toole (Kartini Clinic) and pediatric obesity expert Dr. Evan Nadle...

29 Joulu 20251h 15min

I’m Working Out—So Why Am I Getting Fatter?

I’m Working Out—So Why Am I Getting Fatter?

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor talk with exercise physiologist Russell Cunningham and patient Becca Wert about a counterintuitive reality: for some people, ...

22 Joulu 20251h 2min

The Latest GLP-1 News

The Latest GLP-1 News

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor unpack the biggest GLP-1 headlines from around the world—from the World Health Organization’s first-ever GLP-1 obesity guidel...

15 Joulu 202539min

Listener Mailbag: Set Point Theory, Trauma & Metabolism, and Why 1200 Calories Can Still Lead to Weight Gain

Listener Mailbag: Set Point Theory, Trauma & Metabolism, and Why 1200 Calories Can Still Lead to Weight Gain

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor answer listener questions about BMI cutoffs, weight cycling, metabolic adaptation, trauma, GLP-1 differences, and why some pe...

8 Joulu 202547min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
rss-hanna-tikander
tiedenaiset-podcast
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-pitaisko-erota
rss-kuumilla-aalloilla
vakeva-elama-viisaampi-mieli-vahvempi-keho
rss-narsisti
junnut-pelissa
rss-pt-paahtio
puhu-muru
katilon-kahvitunti
rss-kyykkya-ja-kuoharia
meditaatiot-suomeksi
paritellen
fitnessvastaanotto
rss-sanelunpurku-podcast
rss-seuraava-potilas
terapiassa